Editor: Vlad Rothstein | Tactical Investor
Drinking Red Wine With Type 2 Diabetes
In the battle of the wines, when it comes red versus white, science tends to side with the darker blend. Drinking red wine has been touted for its health benefits, especially for diabetics, from improving cholesterol to blood sugar levels.
Resveratrol, an antioxidant commonly present in some wine and fruits, is found to have a protective effect against heart disease by improving vascular function and reducing inflammation. The natural compound is known to slow down premature aging of the arteries by activating SIRT1 — a gene that slows down the aging. Specifically, it’s able to reduce the stiffness of the aorta, which is the main artery that transports blood from the heart and into the rest of the body.
In the new study, presented at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology and Peripheral Vascular Disease 2017 Scientific Sessions in Minnesota, researchers found a 300 milligram (mg) per day dose of resveratrol decreased aortic stiffness by 9 percent in type 2 diabetes patients. Resveratrol’s effect was also seen with a 100 mg daily intake of resveratrol, which reduced aortic stiffness by 4.8 percent. Contrastingly, patients given the placebo treatment saw the opposite effect and experienced an increase in aortic stiffness.
“The effect of resveratrol may be more about improving structural changes in the aorta, and less about the relaxation of blood vessels, and people with more normal aortic stiffness may not get as much benefit,” said Dr. Naomi M. Hamburg, senior author of the study, and chief of the vascular biology section at the Boston University School of Medicine in Massachusetts, in a statement. Full Story
Red wine boosts diabetics’ heart health
Lovers of fine red wine can finally take heart. Scientists have been studying the popular drink for years and produced compelling evidence that it promotes longevity, protects against certain cancers, and boosts cardiovascular health. Now a new, long-term randomised controlled trial – the gold standard of evidence-based medicine – shows that daily moderate intake of red wine protects heart health in type 2 diabetics. That’s important, the Israeli-led team says, because diabetics are more susceptible to developing cardiovascular diseases than the general population. – Marika Sboros Full Story
Red wine and Type II Diabetes
A glass of red wine every night may help people with type 2 diabetes manage their cholesterol and cardiac health, according to new findings from a two-year randomized controlled trial (RCT) led by researchers at BGU. Additionally, both red and white wine can improve sugar control, depending on alcohol metabolismgenetic profiling. In this first long-term alcohol study “Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes“, just published in the prestigious Annals of Internal Medicine, the researchers aimed to assess the effects and safety of initiating moderate alcohol consumption in diabetics, and sought to determine whether the type of wine matters.
People with diabetes are more susceptible to developing cardiovascular diseases than the general population and have lower levels of “good” cholesterol. Despite the enormous contribution of observational studies, clinical recommendations for moderate alcohol consumption remain controversial, particularly for people with diabetes, due to lack of long-term, randomized controlled trials, which are the “holy grail” of evidence-based medicine.
Is Red Wine Is A Diabetic’s Best Friend
The researchers concluded that “initiating moderate wine intake, especially red wine, among well-controlled diabetics, as part of a healthy diet, is apparently safe, and modestly decreases cardio-metabolic risk. The differential genetic effects that were found may assist in identifying diabetic patients in whom moderate wine consumption may induce greater clinical benefit.”
The researchers also found that only the slow alcohol-metabolizers who drank wine achieved an improvement in blood sugar control, while fast alcohol-metabolizers (with much faster blood alcohol clearance) did not benefit from the ethanol’s glucose control effect. Approximately one in five participants was found to be a fast alcohol-metabolizer, identified through ADH enzyme genetic variants tests.
Wine of either type (red or white) did not effect change in blood pressure, liver function tests, adiposity, or adverse events/symptoms. However, sleep quality was significantly improved in both wine groups, compared with the water control group. All comparisons were adjusted for changes in clinical, medical and drug therapy parameters occurring among patients during the years of the study. Full Story
Other Stories of Interest
Fake news & Weak Economy Can’t Stop Stock Market Bull (July 6)
Technica Analysis of Stock Trends; Why both Technical Analysis & Fundamentals fail (April 8)
Stock Market Trends-Is the Stock Market Heading for a Crash? (April 4)
Political Polarisation: Trump-Brexit win Polarisation Grips Financial advisers (March 31)
War Between the U.S. & China will Destroy World Economy (March 24)
